Clinical Trials · NCT07567001
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 5,610
- Start date
- May 2026
- Locations
- 838 sites, 27 countries
- Primary endpoint
- Time to first occurrence of a composite Heart Failure (HF) endpoint consisting of cardiovascular (CV) death